Investors in Zhejiang Zhongxin Fluoride MaterialsLtd (SZSE:002915) From Three Years Ago Are Still Down 44%, Even After 10% Gain This Past Week

Simply Wall StNov 25 02:19 ET

10 consecutive trading limits! The big monster stock makes a comeback.

What exactly are you speculating about?

Gelonghui FinanceNov 23 04:35 ET

Zhejiang Zhongxin Fluoride Materials (002915.SZ): The company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development.

Gelonghui October 18th: Zhejiang Zhongxin Fluoride Materials (002915.SZ) stated on the investor interaction platform that the company's pharmaceutical intermediates can be used in the field of CRO (Contract Research Outsourcing) pharmaceutical research and development. Pharmaceutical intermediates are important chemical raw materials in the drug synthesis process, playing a key role in the research and development of new drugs. Currently, the company has formed pharmaceutical intermediates represented by the 2,3,4,5-tetrafluorobenzene series, nanosar acid, and trifluoroacetic acid series. It has a provincial-level small and medium-sized enterprise technology center, a provincial-level enterprise research institute - Zhejiang Zhongxin Fluoride Chemicals and New Materials Research Institute, dedicated to pharmaceutical intermediates.

Gelonghui FinanceOct 18 03:46 ET

Zhongxin Fluoride: Report for the third quarter of 2024

SZSIOct 17 12:00 ET · Announcements

Zhejiang Zhongxin Fluoride Materials (002915.SZ) released its performance for the first three quarters, with a net loss of 42.99 million yuan.

zhejiang zhongxin fluoride materials (002915.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...

Zhitong FinanceOct 17 04:23 ET

Zhejiang Zhongxin Fluoride Materials (002915.SZ): The net loss in the third quarter was 19.8661 million yuan.

Gelonghui October 17th | Zhejiang Zhongxin Fluoride Materials (002915.SZ) released the third quarter report of 2024, with a revenue of 0.382 billion yuan, a year-on-year increase of 14.70%; net income attributable to shareholders of the listed company -19.8661 million yuan; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses -19.9351 million yuan; basic earnings per share -0.0608 yuan.

Gelonghui FinanceOct 17 04:23 ET